Max Meyrath
Impact in
- Oncology top 10%
- Chemokine receptors and signaling
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 14
- Chemokine receptors and signaling 12
- Pancreatic and Hepatic Oncology Research 1
-
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 6
- Co-authors
- Andy Chevigné (19 shared papers)Martyna Szpakowska (18 shared papers)Markus Ollert (4 shared papers)Elin Sjöberg (2 shared papers)Tomasz Uchański (5 shared papers)Martin Augsten (2 shared papers)Arne Östman (2 shared papers)Evi Kostenis (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Methods in enzymology on CD-ROM/Methods in enzymology (2 papers)ACS Pharmacology & Translational Science (2 papers)Nature Communications (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- LuxembourgBelgiumGermany
In The Last Decade
Max Meyrath
22 papers receiving 584 citations
Peers
Comparison fields: 5 of 67
- Oncology 306
- Immunology 213
- Toxicology 25
- Hepatology 42
- Cellular and Molecular Neuroscience 97
Countries citing papers authored by Max Meyrath
This map shows the geographic impact of Max Meyrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Meyrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Meyrath more than expected).
Fields of papers citing papers by Max Meyrath
This network shows the impact of papers produced by Max Meyrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Meyrath. The network helps show where Max Meyrath may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Meyrath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 87 | |
| 2 | 2020 | 83 | |
| 3 | 2019 | 50 | |
| 4 | 2017 | 50 | |
| 5 | 2016 | 46 | |
| 6 | 2014 | 35 | |
| 7 | 2021 | 33 | |
| 8 | 2018 | 28 | |
| 9 | 2021 | 27 | |
| 10 | 2020 | 27 | |
| 11 | 2021 | 25 | |
| 12 | 2020 | 23 | |
| 13 | 2020 | 23 | |
| 14 | 2022 | 13 | |
| 15 | 2022 | 13 | |
| 16 | 2018 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2019 | 3 | |
| 20 | 2025 | 1 |
About Max Meyrath
Max Meyrath is a scholar working on Oncology, Immunology, Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases, having authored 22 papers that have together received 585 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (12 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (6 papers), Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (4 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Hepatitis C virus research (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (306 citations), Immunology (213 citations), Toxicology (25 citations), Hepatology (42 citations) and Cellular and Molecular Neuroscience (97 citations). Max Meyrath has collaborated with scholars based in Luxembourg, Belgium and Germany. Frequent co-authors include Andy Chevigné, Martyna Szpakowska, Markus Ollert, Elin Sjöberg, Tomasz Uchański, Martin Augsten, Arne Östman, Evi Kostenis, Julien Hanson and Oliver Frings. Their work appears in journals such as Frontiers in Immunology, Methods in enzymology on CD-ROM/Methods in enzymology, ACS Pharmacology & Translational Science, Nature Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.